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I
Foreword 
 
 
My plan of study draws upon a governmentality framework to investigate new modes of social 
service planning in the City of Toronto, with a particular focus on policy debates concerning 
supervised injection sites. My first learning goals are: to explore and expand my knowledge of 
governmentality studies; and to successfully create a governmentality analytical framework for 
debates relating to the study of social service provisions. My analysis of the Toronto Drug 
Strategy and media reports about supervised injection sites achieves this. My second learning 
goal pertains to the study of urban planning in Toronto. This learning goal has been achieved by 
investigating City of Toronto planning reports, as well as official plans and bylaws relevant to 
the provision of social services, in order to develop an analysis City of Toronto planning for 
social services. Lastly, my research topic also allows me to work towards my third learning 
objective to further research on social policy. I have attained this by developing an analysis of 
the institutional response and approach to “social” problems in Toronto.  
 
  
II
Abstract 
 
Drawing on Michel Foucault’s bio-power lens, this paper argues that supervised injection sites 
are political and governmental spaces that have emerged from the harm reduction movement as 
an alternative to prohibitionist approaches to drug use. Within this movement, harm reduction as 
a “health” policy has emerged as the new truth discourse in which to justify supervised injection 
sites as the most appropriate technique to address urban drug problems. However, supervised 
injection sites do not actually function as a form of health care in the traditional sense of 
optimizing life and wellbeing. Drawing upon secondary and primary textual sources and using 
the creation of The Toronto Drug Strategy (2005) as my analytical focus I show how supervised 
injection sites operate new governmental and political spaces that naturalize drug use and the 
various modes of disadvantage that often go hand-in-hand with it. Rather than promoting health, 
such undertakings normalize the dying body outside the health promotion frame. 
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Introduction 
 
Using Toronto as my primary research site, this paper investigates supervised injection sites 
(SIS) as political and governmental spaces. Briefly, SIS’s are legal facilities in which pre-
obtained drugs can be consumed with access to clean equipment in a hygienic and medically 
supervised milieu. The expressly stated purpose of these facilities is to prevent overdoses and the 
spread of blood borne viruses. In recent years, the suitability of SIS’s for Toronto has been a 
matter of intense discussion. These debates are set against the backdrop of a broader SIS 
movement, particularly in relation to the political struggles over the existence of Insite, North 
America’s first SIS located in Vancouver’s East End. The Toronto Drug Strategy, written by the 
Toronto Drug Strategy Advisory Committee, chaired by former Councilor Kyle Rae and released 
in October 2005, has been a focal point for policy development assessments of the potential 
benefits to be gained from launching one or more SIS’s in Toronto. The local media has kept 
these issues in the public eye and a recent Supreme Court of Canada decision has opened the 
possibility for the creation of SIS’s in Toronto.  As yet, the political will for such an initiative is 
not forthcoming but the discussions surrounding the possibility offer a rare opportunity to 
examine the governmental and political implications of supervised injection sites. 
 My contribution to these discussions is to draw upon the lens of biopower introduced by 
Michel Foucault. Paul Rabinow and Nikolas Rose (2006, 197-198) have “extended and clarified 
Foucault’s notion of biopower by delineating its three main elements.” It “includes a ‘truth 
discourse’ pertaining to the vital attributes of human life that are espoused by experts and 
‘authorities considered competent to speak that truth.’  This truth discourse is linked to strategies 
aimed at acting upon human life ‘in the name of life and health.’  Finally, these discourses and 
strategies are tied to ‘modes of subjectification, through which individuals are brought to work 
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on themselves, under certain forms of authority, in relation to truth discourses, by means of 
practices of the self, in the name of their own life or health, that of their family or some other 
collectivity, or indeed in the name of the life or health of the population as a whole’” (Murray, 
Draft Paper). As I shall demonstrate, the debates concerning the possibility of creating a SIS in 
Toronto constitute a biopolitical struggle. It is a set of contestations over life, how life should be 
promoted (or not), by whom and to what ends.  
With these themes in mind, the analysis is divided into five sections. Section 1 assesses 
how supervised injection sites work and how these facilities function as a form of governance. 
Section 2 two provides a broad overview of the harm reduction movement from which 
supervised injection sites have emerged from. Section 3 discusses Insite, North America’s only 
supervised injection site, located in Vancouver, which has become a site of knowledge 
transmission for the Toronto context. Section 4 provides a critical analysis of the Toronto Drug 
Strategy, which both enables the possibility of a supervised injection site in Toronto and defines 
the “problem” of drug use in the City and the appropriate solutions. Lastly, Section 5 is a 
discourse analysis of Toronto print media, which explores three emerging editorial themes – risk, 
loss of the productive body, and the spatial and criminal implications of the addicted body. 
Through my analysis, I will indicate how various issues concerning the creation of an SIS in 
Toronto are fundamentally biopolitical struggles over what life is, whose life is valued, and how 
such value ought to best to be protected or managed. 
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1. Supervised Injection Sites as Governance 
 
This section provides a broad overview of the discursive shift in debates about supervised 
injection sites, sometimes also referred to as safe or safer injection sites (SIS), which have 
emerged as a new technique to address urban intravenous drug use1. They are increasingly being 
deployed in urban centres internationally and offer a clean and supervised space for injecting 
illicit drugs. Supervised injection sites are located within the larger harm reduction movement, 
which seeks to mitigate the risks associated with drug use, rather than stop drug use in and of 
itself. These facilities are increasingly being articulated through a discourse of health and 
advocated for on the basis of access to health care. More implicit is their role in urban spatial 
politics, and most importantly, in creating the “good drug user” who conducts his or her drug use 
only within supervised injection sites. The “good drug user” conducts their drug use in a 
palatable, non-visible manner that reduces risk both to themselves and others.  In this way, we 
see how at least one narrative about supervised injection sites is directly tied to efforts to produce 
subjects both willing and able to conduct their lives in accordance with norms that align with 
health, order, and stability, all of which support the overarching governmental aim of creating 
contexts for the production of wealth and capital. 
Supervised injection sites are often understood as a “health” service and several countries 
have started to include these services as part of the provision of public health resources. Canada, 
Germany, the Netherlands, Switzerland, Spain and Australia have supervised injection facilities 
                                                          
1
 It should be noted that there is disagreement regarding the appropriateness of using “safe” or “safer” to describe injection 
facilities. 
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(Broadhead et al., 2002, 331). Supervised injection sites are often described as “legal facilities 
that enable the consumption of pre-obtained drugs in an anxiety and stress free atmosphere, 
under hygienic and low risk conditions” (Broadhead et al., 2002, 333). Users must register, sign 
in on all subsequent visits, and also might have to sign a liability release form (Broadhead et al., 
2002, 336). The “clients” are typically given some or all of the following equipment: syringes, 
water, a dissolving agent, a cooker, cotton filters, a tourniquet, alcohol wipes, bandages, and 
paper towels to clean up after themselves (ibid). Injection rooms typically have seven to twelve 
injection spaces and users are allowed 30-45 minutes to inject, always with at least one staff 
member present (Broadhead et al., 2002, 336-337). The explicitly stated main function of 
supervised injection sites is to prevent the spread of blood borne viruses (HIV/AIDS, Hep C) and 
to stop overdoses. In this way, SIS’s are not meant to treat addictions. Rather, they take 
addictions as a personal choice, but one that can be potentially disruptive. SIS’s are therefore, in 
part, techniques for regulating choices that might otherwise interfere with the freedom of others 
(e.g., spread of disease, crime, open drug scene, etc.). 
 Supporters of supervised injection sites see them as representing a shift from punitive and 
repressive measures to the better management of drug use, defined by the need for regulating 
risks and stabilizing the socio-spatial order in the name of “public health” (Fischer et al., 2004, 
357).  Until the late 1990’s, resources dedicated to combating illicit injection drug use in 
Canada had been predominately directed towards criminal justice interventions. As Table 1 
shows, data taken from the Canadian Centre of Substance Abuse, which was used to justify the 
Vancouver Four Pillars Approach, estimated that the total cost in 1998 of health care and law 
enforcement in British Columbia was $96 million (Millar, 1998, 18-19). The cost of police 
enforcement alone was more than the entire medical costs for British Columbia in 1998. These 
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statistics are now outdated by more than ten years, yet policing continues to receive considerable 
allocation in budgets and policy documents.  
Table 1: Comparison of Health and Policing Costs Relating to Drugs in Vancouver 
Direct Health Care Costs $ 
Hospitalization $5,172,000 
Co-Morbidity $2,400,000 
Residential Care $4,854,000 
Non-residential Treatment $1,316,000 
Ambulatory Care $1,458,00 
Prescription Drugs $1,500,000 
Other Health Care Costs $321,000 
Total $17,021,000 
    
Law Enforcement   
Police $37,161,000 
Courts $20,020,000 
Corrections $20,020,000 
Customs and Excise $1,508,000 
Total $78,710,000 
Total Direct Costs $95,731,000 
Source: Millar, 1998, 18-19.  
 
 One of the critical turns in public thinking about drug policy was the appearance of HIV 
in urban drug scenes. In part, this has re-defined the “drug problem” as a health issue for 
intravenous drug users and the population at large. The most prominently articulated public 
health concerns became intravenous drug users who share and re-use needles, leave their 
discarded equipment in public places, and engage in sex work (Fischer, 1995, 400). The 
implications of HIV infection and the threat to health not only in the drug using community, but 
to the "innocent public" made policy and decision-makers conclude that pragmatic health-
oriented measures had to be taken. What helped to further crystallize the health-drug “risk” 
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discourse were studies that confirmed that the threat of AIDS generally did not stop users from 
injecting opiates. Research also showed an association between drug use and sex work. For 
example, in Frankfurt it was estimated that 8o percent of female heroin users were engaging in 
“prostitution activities” in order to pay for drugs (Fischer, 1995, 400). Inferred from this research 
was the possibility that these female injection drug users could have engaged in unsafe sex 
practices with a large number of clients (ibid). With this came the realization that current 
modalities of “treatment,” namely prohibitionist and criminogenic techniques, were inadequate 
to address the problem of “drugs” and “drug users.”  These issues were now seen to be more 
threatening, moving beyond the intravenous drug using population to the population at large.  It 
was here, where the mainstream population was seen to be at risk that we see the rise of a new 
discourse of “health” interventions. 
With the rise of public health discourses on drugs, “treatment” was now not simply or 
even necessarily aimed at stopping an individual from using drugs. Rather, the goal was to 
address the larger project of teaching good citizenship as a means to reduce the harms of drug 
use (Moore, 2007, 33).  Put differently, with SISs we see the general governance of drug users 
transforming from punishment to discipline and normalization (Bergschmidt, 2004, 63). As a 
matter of practice, this redefinition of treatment has been linked to the creation of various “harm 
reduction” approaches, as discussed in the next section, such as supervised injection sites. With 
the emergence of drug use being mainly articulated through discourses of health risks, 
intravenous drug users are now officially regarded as a primarily ill and diseased (e.g., addicted) 
rather than a primarily criminal population that must be stabilized through law and order 
approaches (McCann, 2008, 8). Nevertheless, while new techniques have purported to move 
beyond the criminal addict identity, a deeply embedded organizational and professional 
  
7 
mentality remains that seeks to change these former “lawbreakers” to improve their chances of 
becoming law-abiding citizens (Moore, 2007, 27). The governance of drug users is a consistent 
feature of contemporary governmental responses to drug use. What has changed, are the 
modalities to this end. 
 
 
2. Harm Reduction 
 
The rise of what might be called a “supervised injection site movement” is closely linked to the 
emergence of “harm reduction” as a new policy idea.   The Canadian Centre on Substance Abuse 
defines harm reduction as a policy or program aimed at decreasing the adverse health, social, and 
economic consequences of drug use without requiring abstinence from drug use (Millar, 1998, 
24). Harm reduction implies a concern with reducing the negative outcomes of drug use for the 
society, which includes those members of society who happen to use drugs (Lenton and Single, 
1998, 218).  One of the most common criticisms of harm reduction programs is that they are the 
first step towards the legalization of currently illegal drugs (Jaralis, 1995, 11). Other critiques 
argue that harm reduction enables society to continue causing harm to individuals without 
acknowledging the social, legal and economic source of the harms (Roe, 2005, 246).  
The earliest harm reduction strategies included needle exchange programs, methadone 
maintenance programs, outreach programs for high-risk populations, law enforcement 
cooperation, and prescription of heroin and other drugs (Roe, 2005, 246). The notion of reducing 
harms posed by drug use arose in The Netherlands in the 1960’s with the ‘balance of harms 
approach.’ This challenged to the idea that strict enforcement was the best approach to drug use 
(Roe, 2005, 244). Harm reduction as a policy movement can be grouped into three, loosely 
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defined, phases. The first phase stemmed from concern in the 1960’s about the health risks 
associated with tobacco and alcohol use in the population. The second phase began in the 1980’s 
with a sharp focus on AIDS prevention among injection drug users. We are now currently in the 
third phase, where an integrative public health perspective is being developed for all licit and 
illicit drugs (Cheung, 2000, 1699).  
From the perspective of bio-power, in harm reduction discourses the drug addict and 
addiction are not natural truths. They are modern discoveries and identities that were exposed in 
order to facilitate a practice of governing (Moore, 2007, 125). Harm reduction accepts the 
occurrence of drug use and tries to mitigate the harms associated with it, as opposed to pushing 
an abstinence agenda. Substance abuse is a “problem” that is very scientifically accessible and 
can be read as an exclusively individual behaviour that enables the facilitation of assigning 
responsibility to the individual for how they conduct their drug use (Moore, 2007, 50). Drug 
users, once identified, can be subjected to interventions, often times in ways that overlap with 
socio-economic status, race, gender, etc. (Moore, 2007, 126).  Interventions for upper class 
people have traditionally meant rehabilitation clinics (ibid). For “others,” disadvantaged and 
often racialized and gendered populations, it has meant criminalization, forcible confinement, 
incarceration and disenfranchisement (ibid). Harm reduction has emerged as a new technique 
that most often is used to address “poor” drug use and is an attempt to not only prevent further 
harm to drug users, but also prevent harm from drug users to the general population. In this 
sense, the drug user is constructed as more than simply an undesirable body, but as an active 
health and economic threat to the productive and consuming population at large, as well as a 
threat to the wellbeing of the city. Within the harm reduction movement, supervised injection 
sites have surfaced as a new intervention to reorder urban spaces to facilitate processes of 
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governance.  Thus, rather than being outside of government, the drug user, “bad” and “good,” is 
integral to governmental objectives, the former being the problem and the latter the solution. 
During the 1990’s in North America, police and law enforcement departments routinely 
alerted the public to the possible presence of a serious drug problem in a local area by 
publicizing drug-related arrests, drug seizures and incarceration records (Cheung, 2000, 1698). 
Media reports tended to copy such behaviour by supplying anecdotal stories about victims who 
had “fallen prey” to drug abuse (ibid).  The result in some cases was the manufacturing of a 
“moral panic” among the public. Public belief in an ever-growing drug problem fuelled the 
prohibitionist reaction to drug use and the user, which assumed illicit drug to be a morally 
corrupt behaviour violating mainstream norms (ibid). From this perspective, the control of such 
behaviour required strong law-enforcement and a drug policy that declared a “war” on drugs and 
heavily punished drug users (ibid).  Canada followed this general trend. Resources were 
dedicated to combating illicit injection through criminal justice interventions – 94 percent of the 
454 million dollars dedicated to addressing illicit drug use in 2001 was spent on enforcement and 
justice initiatives (W. Small et al., 2006, 85).  
In the early 1990’s, Vancouver was in the midst of an HIV epidemic in the eastern part of 
the city. In 1991 the Downtown Eastside saw a sudden increase in injection cocaine use and a 
general shift from heroin to cocaine as the drug of choice. This change increased the opportunity 
for sharing syringes, as cocaine users inject much more frequently than users of other drugs 
(Millar, 1998, 17).  Injection drug users were infected with HIV at a rate three to four times 
higher than seen before (Smith, 2003, 500).  By 1998 it was estimated that there were roughly 
15,000 regular, frequent injection drug users in British Columbia (and likely many more 
occasional users). Most of these people were concentrated in the Downtown Eastside of 
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Vancouver. Of the 15,000, approximately 25 percent were HIV positive and about 88 percent 
had Hepatitis C (Millar, 1998, 17). Within this, it was estimated that close to half of the injection 
drug users either residing or frequenting the Downtown Eastside were infected with HIV (Smith, 
2003, 500).  
Between 1993 and 1997 over half of British Columbia’s total 1,200 drug overdose deaths 
occurred in the Downtown Eastside, which led the Richmond and Vancouver Health Board to 
declare a state of health emergency (Millar, 1998, 17). These issues were also frequently framed 
as economic burdens. Data from the Canadian Centre of Substance Abuse estimated that in 1998 
illicit drug use cost the British Columbia economy $209 million annually and estimated that 
direct costs arising from health care and law enforcement cost about $96 million annually 
(Millar, 1998, 18-19). During the health emergency, the B.C. Centre for Excellence in 
HIV/AIDS identified four factors in particular that were associated with injection drug users 
becoming HIV infected: borrowing syringes, unstable/poor quality housing, frequent injection 
(more than four injections a day) and cocaine use (ibid).  
It was in this context that a harm reduction movement emerged in Vancouver as an 
alternative to enforcement and as an attempt to prevent HIV and AIDS moving from intravenous 
drug users and sex workers to the general population (Roe, 2005, 244). It became apparent that 
existing approaches were ineffectual in ceasing drug use and exacerbating the escalating health 
crisis. Nowhere was this ineffectiveness more obvious than with the 2003 large-scale police 
crackdown, referred to as the Citywide Enforcement Team (CET), which began in the 
Downtown Eastside, and was the largest visible enforcement operation ever undertaken in the 
neighbourhood (W. Small, et al., 2006, 86). Human Rights Watch conducted an investigation 
and reported observations of police misconduct, including instances of excessive force, 
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harassment and illegal searches. The report suggested that the CET compromised public health 
by discouraging drug users from accessing health services by driving them underground, and so 
increased risks associated with unsafe injection and overdose (ibid). The most immediate 
consequence of the increased police presence was the shift in injecting locales to less visible 
outdoor locations (W. Small et al., 2006, 88). The increases in street level enforcement also 
encouraged movement into less desirable and more dangerous injecting venues – those who 
continued to use in public venues sought secluded and private niches where they could escape 
the scrutiny of police officers (W. Small et al., 2006, 8). Drug users were at a higher risk because 
they were being forced into areas that they did not know and where there were no services that 
provided clean works or help. Users who injected in public settings in the Downtown Eastside 
were increasingly likely to be interrupted by the police while injecting, creating a climate that 
was not conducive to safer injecting practices as had been the case prior to the escalation in 
police activity (ibid). The resulting effect was hasty injections, shared syringes, and ‘missed’ 
injections – accidental subcutaneous injections instead of intended intravenous injections (ibid). 
Police also on occasion confiscated or destroyed syringes during encounters with drug users, 
including new sterile syringes (W. Small et al., 2006, 90). While it is legal to carry syringes, 
being found carrying new or used syringes often lead to more problems when drug users 
encountered police officers, and encouraged unsafe disposal as well as sharing syringes (ibid). 
What these examples highlight is that laws and policies pertaining to illicit drugs, as well as the 
enforcement practices used on the street, are important contextual factors that can partially 
determine a drug user’s access to harm reduction programs (W. Small et al., 2006, 91).  
After Human Right Watch findings were released, Vancouver police officers began to 
practice alternatives to arrest and confiscation of equipment, and increasingly began to rely on 
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warnings to drug users and referrals to addiction treatment. Police also started to avoid 
interacting with drug users at the point of injecting, as this practice often resulted in ‘preventable 
harms’ such as syringe sharing (W. Small et al., 2006, 92-93) As this example demonstrates, 
what can result from increased police presence and lack of police training are practices that run 
counter to harm reduction initiatives.  
Even before the 2003 police crackdown in Vancouver’s east end, a coalition of public 
health authorities and activists began to challenge the traditional model of enforcement of drug 
laws and advocated for adjustments to and reform of social and legal policies that had grown 
unpopular and in many cases expensive or difficult (W. Small et al., 2006, 92-93). The goal was 
not to legalize drugs or promote abstinence. At the practical level, the aim of harm reduction was 
to reduce the more immediate harmful consequences of drug use through pragmatic, realistic and 
low-threshold programs (Cheung, 2000, 1699). For these harm reduction proponents, police 
crackdowns might succeed in reducing the visible aspects of street drug markets, but also can be 
associated with negative public health consequences, including reductions in needle exchange 
utilization, increases in syringe sharing, unsafe injecting and improper syringe disposal. This 
health crisis was an important part of the genesis of Insite and the adoption of other harm 
reduction techniques in Vancouver.  
 
3. Insite 
 
The Vancouver Agreement set the framework for Insite’s operations. Created in 2000 and 
expired in 2010, the agreement was a tri-level government agreement (federal, provincial and 
municipal) aimed at addressing social, health, economic and safety issues in Vancouver’s inner 
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city, with a particular focus on the downtown eastside (Vancouver Agreement, 2012).  The 
Agreement laid out funding and policy responsibilities for each government level. As part of this 
agreement, the City of Vancouver released the Framework for Action: A Four Pillar Approach 
to Vancouver`s Drug Problems (2000). The Framework for Action laid out four broad goals: 
public and federal responsibility; public order; public health; and coordinate, monitor and 
evaluate. In addition, the document set out 36 actions to achieve the goals (City of Vancouver, 
2000, 2-3). The Framework also introduced the fourth pillar of harm reduction to be used in 
conjunction with the traditional approaches to drug use of prevention, treatment and enforcement 
(City of Vancouver, 2000, 3-4). With the introduction of a harm reduction approach, discussions 
around a supervised injection site became possible.  The emergence of harm reduction as an 
official policy marked a shift away from prohibitionist approaches. This transformation was 
shaped by the context of increased overdose deaths and HIV infections and their effects on urban 
economies. Statistics such as the $500,000 lifetime cost per each new HIV infection (Insite 
Numbers, 2009) served to identify drug use as both a health and economic risk to cities.  
 Insite was officially opened in June 2003 under the auspices of Vancouver Costal Health 
and in partnership with the Portland Hotel Society Community Services (a non-profit 
organization created in 1993 that provides services for persons with concurrent disorders) as a 
research facility (Legal Status, 2009). Health Canada initially granted Insite a three-year 
exemption under Section 56 of the Controlled Drugs and Substances Act, which allowed drug 
users to poses narcotics on site, for the purposes of consumption only, an otherwise illegal 
action.  In 2002 The Portland Hotel Society began operating what would later become Insite. 
While waiting for government approval of the legal exemption, a small storefront unofficially 
opened that offered a limited number of spaces for injection, supervised by a volunteer 
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community nurse (Small et al., 2006, 78). Although the application to Health Canada was well 
underway, the establishment of the unsanctioned facility was done to put pressure on policy 
makers to move quickly on a sanctioned site. Insite became an officially sanctioned facility in 
2003, as previously mentioned.  
 Located at 139 Hastings Street in Vancouver’s Downtown Eastside, Insite is not only 
North America’s first and currently only legal supervised injection site but also a uniquely 
situated socio-economic-political space. The Downtown Eastside has a large concentration of 
low-income single room occupancy hotels, a high prevalence of mental illness among the 
population, and is generally seen as the “epicenter” of Vancouver’s illicit drug and sex-trade 
economies (Wood and Kerr, 2006, 55-56). The Downtown Eastside is also the most central low-
income neighbourhood in Vancouver. By 1998, overdose from injection drug use had become 
the leading cause of death for adults aged 30-49 in British Columbia, with more than 300 deaths 
annually (Millar, 1998, 5). The leading cause of HIV infection had become injection drug use 
and there were epidemics of hepatitis B and C related to injection drug use as well (ibid). These 
deaths were disproportionately concentrated in the Downtown Eastside, as previously discussed.  
It is in this setting of extreme disadvantage that Insite seeks to fulfill its mandate, which 
is to be accessible to injection drug users who are not well connected to “health care.” Insite 
defines clients who are not well connected to health care as people who use more than one drug; 
people who suffer from both addiction and mental illness; people who are homeless, live in 
shelters or have substandard housing and people who have tried unsuccessfully before to quit 
their addiction (Overview, 2009).  Insite participants have access to a 12-seat injection room 
where they can inject their own drugs under the supervision of nurses and trained staff. Insite 
provides clean injection equipment, including syringes, sterile cookers, filters, water and 
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tourniquets (ibid). After injecting, participants move to a post-injection room where they 
stabilize before leaving the facility. Insite staff are also on-hand to connect participants with 
other services, including primary care for the treatment of wounds, abscesses and other 
infections, addiction counselling and peer support and referral to treatment services such as 
withdrawal management and opiate replacement therapy. Staff can also refer participants directly 
to Onsite, a 30-bed detox and treatment program that is co-managed by Vancouver Coastal 
Health and PHS Community Services Society, located directly above Insite (ibid). 
Insite serves a diverse population of drug users, many with serious concurrent health 
issues. Statistical profiles of Insite clients and DTES drug users present similar patterns. Of 
active drug users in Vancouver, three out of ten in the Downtown Eastside are HIV positive, 
while 18 percent of Insite clients are HIV positive. There is also a very high prevalence of 
Hepatitis C among Vancouver drug users. Nine out of ten injection users in the DTES are 
infected and 87 percent of Insite clients have Hepatitis C (Insite Numbers, 2009). These 
similarities are due in part to the geographic clustering of drug users in the Downtown Eastside 
and the resulting strategic placement of Insite in the DTES; 68 percent of Insite clients live in the 
Downtown Eastside. Additionally, 80 percent have a history of incarceration, and 73 percent of 
users have injected in public before (ibid). Over 1.8 million people have used Insite, and there 
are currently approximately 12,236 registered users (User Statistics, 2011). In the 2010 operating 
year there were 312, 214 visits to the site, with an average of 855 visits a day and 587 injections 
each day (ibid). There were 221 overdose interventions, with no fatalities, 3383 clinical 
treatment interventions, 5268 referrals to other social and health services (majority to detox and 
addiction treatment) and 458 admissions to Onsite (ibid). In terms of a drug profile, heroin 
comprised 36 percent of injections in 2010, cocaine 32 percent and morphine 12 percent (ibid). 
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In 2009, 42 percent of injections were heroin, 26 percent were cocaine and 11 percent were 
morphine (Insite Numbers, 2009).  
 The criminal law exemption allowing Insite’s clientele to posses and use illicit drugs on 
the premises, passed by a Liberal federal government in 2003, was extended several times by the 
Liberal and succeeding Conservative federal governments to allow for additional research. 
However, in 2007 the Conservative federal government took the position that the most recent 
extension, set to end on June 30, 2008, would be the last one, effectively leading to the closure of 
Insite (Legal Status, 2009). The federal government did so based on the premise that Insite 
violated federal drug laws.  In August 2007, Vancouver Area Network of Drug Users (VANDU) 
and the Portland Hotel Society mounted a constitutional challenge to the federal government’s 
ability to close Insite, arguing the facility addressed a public health crisis and should be under the 
sole jurisdiction of the Province (ibid). The B.C. Supreme Court ruled in 2008 that the federal 
government did not have the authority to close Insite and struck down sections of Canada’s drug 
laws as unconstitutional, on the grounds that they prevented Insite from operating. The Court 
also granted Insite an immediate exemption and gave the federal government until June 30, 2009 
to amend the country’s drug laws to allow for the medical use of drugs if tied to a health care 
initiative (ibid). The Attorney General appealed this decision to the BC Court of Appeal, but the 
appeal was unsuccessful. This decision allowed Insite to continue operating (Legal Status, 2011). 
The Attorney General filed a further appeal with the Supreme Court of Canada. The case began 
on May 12, 2011 (ibid). On September 30, 2011 the Supreme Court ruled that the Health 
Minister could not deny legal protection to addicts and health care workers who would otherwise 
be penalized by federal drug laws. Thus Insite’s continuance was constitutionally secured and the 
door opened for the possible establishment of SIS facilities in other parts of Canada (Toronto 
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Star, October 1, 2011). Nowhere was this decision more pertinent, perhaps, than in Toronto, as 
the next chapter discusses. 
 
4. The Toronto Drug Strategy 
 
In this chapter, I situate the emergence of supervised injection sites and the City of Toronto’s 
interest in them in relation to a much wider historical context that has centred urban space as a 
key governmental milieu. The genesis of cities is inextricably bound to the quest for order in the 
city. Urban planning emerged in nineteenth century as part of the social reform movement in 
response to the need to exert social control over the emerging “ills” of expanding urban centres. 
Large cities were believed to produce the conditions of social unrest. Social problems (social, 
physical and spiritual) were seen as embodied in the very fabric of the city (Boyer, 1983, 16). In 
the early twentieth century a connection was made between the environmental chaos of the 
“American” city and the social pathologies of urban life. It was believed that with the proper 
environmental conditions, a sanitary, well-ordered environment could confine undesirable traits 
in the population (Boyer, 1983, 18). The physical environment itself could discipline humans to 
“achieve harmonious order with the urban world”, and if a “conducive” social environment was 
provided, it would ensure the stability of the urban social order (Boyer, 1983, 14). Planning 
offered the state the opportunity to intervene into the social and physical city with disciplinary 
intentions, backed by the belief that environmental reform was the most important disciplinary 
order upon which cities would rise (Boyer, 1983, 6). In the large cities of the early nineteenth 
century, urban diseases and the complications of poverty had come to be seen as a collective 
phenomenon and therefore a collective threat (Boyer, 1983, 26). Early urban planners and 
welfare institutions sought not to help the people condemned to tenement cores, but to protect the 
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rest of society from the disorder that threatened to escape from within the city perimeter (Boyer, 
1983, 16). While current city planning is no longer explicitly concerned with moral pathologies 
and social “ills,” planning and other related interventions continue to have spatial implications 
regarding social control and desirable “traits” or bodies. The Toronto Drug Strategy is not 
overtly an urban planning document, yet it has several spatial dimensions that directly seek to 
control a particular kind of urban drug use. The Toronto Drug Strategy has emerged as a new 
technique for exerting social control over urban “disorder” at a time where cities are actively 
trying to market “place” while interacting directly with global flows of capital.  
A new form of boosterism shaped in large measure by Richard Florida’s ideas about 
“creative classes” has emerged at the end of twentieth century and into the twenty-first. The 
context of this emergence is the growing competition among cities for global capital. This 
competition transcends conventional political spaces, at once realigning the salience of the nation 
state as the point of interaction with global circuits while also reinforcing local spaces as key 
economic centres. This realignment has placed an increased focus on place marketing and urban 
boosterism. The physical urban environment itself has become the main attraction of a new 
urban economic order. Richard Florida’s “creative class” ideas are emblematic in this regard. 
Taking hold in many Western cities as governments and policy makers look for a post-industrial 
urban plan, Florida’s central thesis is that the role of place has changed significantly as 
economies continue to transition from traditional industries (such as manufacturing) to high-tech 
and advanced services. While people once followed jobs in the traditional industries, Florida 
argues jobs and industry are what move now, shifting to where clusters of a particular kind of 
person are found. Capital follows a group of highly mobile, creative people who increasingly 
base their location decisions not on where job opportunities are located, but rather on what urban 
  
19
amenities and cultural environments a city has to offer (Donegan and Lowe, 2008, 46). The 
economic prosperity of a city is dependent on how well it attracts and retains this creative talent  
 The City of Toronto has embraced Florida’s work and has released its own “creative” 
policy. In 2003 the City released its Culture Plan for the Creative City, a “ten year strategy to 
position Toronto as an ‘international cultural capital’ while ‘placing culture at the heart of the 
city’s economic and social agenda’” (emphasis added), followed up by the 2008 Creative City 
Planning Framework, a document that states “in order to compete for the talent in the 
international labour market, Toronto must gain a competitive advantage by maintaining robust 
cultural and creative industries” (City of Toronto, 2010). These “culture plans” released with 
numerous other reports and initiatives send a message about what kind of bodies are valued in 
the city. As Richard Florida’s “creative class” is occupationally defined, not everyone can be 
creative in the way that is understood and sold to cities by Florida.  
The Toronto Drug Strategy: A Comprehensive Approach to Alcohol and Other Drugs 
(2005), the first attempt by the City of Toronto to create a comprehensive municipal approach to 
the “drug problem,” follows Florida’s vision.  The physical urban environment is an essential 
component of boosterism practices, which is where the public nature of drug use becomes 
problematic. Public drug use creates an issue both because of its visible nature and because of its 
economic threat to local businesses and larger associated health care costs. Public drug use 
almost always implies poverty, as the user is unable to afford private space to conduct private 
actions in, instead, conducting them in public.  Poor urban drug users are also devoid of the kind 
of cultural and creative capital so valued by Florida.  In this “creative economy” framework 
one’s actions become a sort of goods. Drug users, and the poor and “fallen” more generally are 
perceived as incurring a debt to their “benefactors” (the “state”, social institutions, etc.), which is 
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to be paid in moral, not economic currency (Valverde, 1992, 3-5). As drug users also lack the 
kind of creative currency that is currently valued, the way they pay back what they receive is 
with “moral fibre” (ibid). Moral regulation is its own distinct mode of regulation which now uses 
the language of biomedical science and social work (ibid). Moral regulation is aimed at the 
production of “individual ethical subjectivity and the reproduction of the nation’s moral capital”, 
that is, ensuring the drug user self-regulates in a way that is palatable to the larger population, 
which often focuses on decreasing the public nature of poor urban drug use (ibid).  
The Toronto Drug Strategy’s aim is “the improved quality of life of individuals, families, 
neighbourhoods and communities in Toronto by creating a society increasingly free of the range 
of harms associated with substance use” (City of Toronto, 2005, 7). The Toronto Drug Strategy 
proclaims to be a comprehensive strategy to address both alcohol and drugs at varying levels of 
uses, from recreation to addiction. The document even recognizes that “we are a drug using 
society”, an important acknowledgement for implementing harm reduction procedures (City of 
Toronto, 2005, 2). The strategy also acknowledges: “people of all economic, social and cultural 
backgrounds use both legal and illegal substances” (City of Toronto, 2005, 27). The City also 
recognized, from public consultations, that Torontonians wanted the strategy to treat substance 
use as a health issue (City of Toronto, 2005, 27). However, despite these early assertions, the 
strategy defines and focuses on a very particular kind of user. In the opening pages of the report, 
it states: “most use is harmless and accepted as part of everyday social interactions, some even 
provide health benefits. But, “not everyone uses safely or without causing harm” (emphasis 
added) (City of Toronto, 2005, 2). It is those drug users who do not use safely and cause harm 
that the report focuses on.  
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The Strategy hinges on a particular understanding of the drug problem, which is 
highlighted in two chapters: Chapter 4, entitled “People Who Use Substances”, and Chapter 5, 
“Neighbourhoods and Communities.” These chapters and their associated recommendations set 
out how the problem of drug use is defined in Toronto and what the proposed solutions are. They 
formally lay out who uses drugs in Toronto and the associated effects on the city.   
As a problem, Toronto’s drug strategy defines drug use in much the same manner as 
already discussed with respect to Insite, as a harm reduction and public health matter. While the 
Toronto Drug Strategy borrows heavily from Vancouver’s drug policy framework, it also defines 
the “drug problem” somewhat differently. Toronto does “not have large, concentrated, open drug 
scenes like the Downtown Eastside of Vancouver.” Rather, the city has several smaller spaces 
where drug use is highly visible. Also unlike Vancouver, Toronto has “not had to declare a 
health emergency amongst its injection drug using population” (City of Toronto, 2005, 2-3). 
While crack cocaine has been identified as a larger issue than heroin in Toronto, unsafe 
consumption and disposal practices are still potential issues for police officers not trained to 
properly approach and interact with drug users.  
The report identifies alcohol and crack cocaine as the drugs of most concern for Toronto 
(City of Toronto, 2005 3). Chapter 4, “People Who Use Substances”, outlines, as the title 
suggests, people who use substances in Toronto. Recommendations 4.1 to 4.3 deal with alcohol, 
prescription drugs, and decriminalizing cannabis. Recommendations 4.4 to 4.16 explicitly and 
implicitly deal with crack cocaine usage. Crack cocaine is not typically a recreational drug, so 
the report is addressing people with what can be considered serious addictions. Under Section 
4.5, which discusses the need for expanded harm reduction, the report does acknowledge that 
crack is not an exclusively “poor” drug, explaining that “people from all income brackets use 
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crack cocaine, including well off and privileged people. However, this kind of use is largely 
ignored and rarely profiled” (City of Toronto, 2005, 31). This kind of “well off” and “privileged 
use” is also ignored by the report, without an explanation. This section of the report does serve to 
identify and profile the most marginalized users though, as people “who use crack cocaine, in 
particular people who are homeless or otherwise street involved” (City of Toronto, 2005, 31). 
The issue that arises here is the dichotomy between public and private spaces, and the ability to 
afford a private space. The “well off” crack cocaine user is not considered a problem because 
they most often conduct their drug use in a private space, and are likely “functioning bodies” or 
have another source of monetary support. The “marginalized” crack cocaine user, who the report 
identifies as most often homeless or street involved, is a problem because they do not have a 
private space and therefore conduct private actions, such as drug use, in public spaces. This 
serves to define public crack cocaine use by poor users as the “problem” the report is seeking to 
regulate.  
There is also an associated spatial dimension to the problematizations of drug use. The 
report identifies “pockets of open use, of both alcohol and other drugs, most notably in parts of 
the downtown core. People in these areas of the city tend to be more marginalized because of 
poverty, homelessness, mental health issues and prostitution” (City of Toronto, 2005, 32). This 
downtown sentiment is repeated further on in Section 5, Neighbourhoods and Communities: 
Residents of neighbourhoods with concentrations of illegal drug use and drug 
dealing, such as those in the downtown core of Toronto, sometimes feel unsafe 
and angry about the crime and disorder that is happening in their communities. 
This includes related crime such as prostitution, property theft, violence and 
vandalism (City of Toronto, 2005, 43).  
The strategy considers drug use to be an urban issue, something that occurs most often in the 
downtown core. It recognizes the drug user as a spatial threat to downtown communities, spaces 
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that are becoming increasingly more economically valuable. These statements also identify the 
criminal and spatial implications of the addicted body. There is not only an assumption that the 
drug user’s body will behave criminally and attract criminal behaviour, but that the drug user 
makes a space dangerous, even after they have gone. This assumption is addressed in 
recommendation 5.5 Reduce Drug Related Litter, which identifies as an outcome of public drug 
use: 
...the discarding of paraphernalia such as needles and crack pipes. Some 
neighbourhood areas and city parks are struggling with ways to deal with this 
litter, which can cause health and safety concerns for children and adults who 
want to use these public spaces (City of Toronto, 2005, 46).  
 
The understanding from this then is that the “problematic” drug user in Toronto can then be 
conceptualized as one whose drug use is public, is urban and centralized in nature, and has both 
criminal and spatial implications that produce risk.  
Homelessness and mental health issues are other recurring themes in identifying who 
drug users are in Toronto. Recommendation 4.7 specifically deals with homeless drug users, as it 
seeks to provide more harm reduction in shelters, and identifies alcohol and other drug use issues 
as significant among people who are homeless (City of Toronto, 2005, 33). Recommendation 4.6 
addresses developing a 24 hour crisis centre for short term crisis and care support, because 
homeless shelters have become the “de facto” support system for “people abandoned by every 
other part of our health and social safety net” (City of Toronto, 2005, 32). Recommendation 4.8 
seeks to increase case management services, which are “particularly helpful for vulnerable 
groups such as youth, or people with multiple health and/or mental health issues” (City of 
Toronto, 2005, 34). 
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 Poverty is also particularly prevalent in defining drug use in Toronto. Section 4.10 
discusses the need for increased day programming, as  
...financially stable people tend to have a wide range of pursuits and activities 
to occupy their work and leisure time. People who are not working and/or 
who are struggling to on a limited income have fewer resources for such 
activities to engage their time (City of Toronto, 2005, 36).  
 
Section 4.14, which discusses improving income security for “vulnerable groups”, makes a 
stronger statement about the connections between unemployment, poverty and drug use, 
declaring that  
...the resulting combination of poverty and addiction and/or mental health 
issues make people more vulnerable to substance use and to engaging in 
prostitution, drug dealing and other crimes in order to support their drug use 
(City of Toronto, 2005, 39).  
 
The vision then that comes out of this document is not of an all-encompassing approach 
to drugs, spanning from recreation to addiction, across socio-economic statuses. Rather, the 
Toronto Drug Strategy defines the drug user (and therefore the problem to be regulated) as most 
likely to be a poor, urban crack cocaine user who uses in visible, public spaces, most likely 
experiences concurrent addiction and mental health issues, has a high probability of being 
homeless and most likely has engaged in criminal activities, including theft and prostitution.  
From a biopolitical stance, we see how the Toronto Drug Strategy is constituting the drug using 
subject as means to make it a space for better governance. 
 In terms of proposed solutions, the Toronto Drug Strategy makes recommendations based 
on four principles that align with The Vancouver Agreement (2000) and the Framework for 
Action: A Four Pillar Approach to Vancouver’s Drug Problems (2000, adopted by City Council 
  
25
in 2001): prevention; harm reduction; treatment and enforcement. Despite overtures to a health 
promotion model, the “criminal” aspect of drug use is not divorced from proposed health-
oriented approaches. The most frequent recommendation in the Toronto Drug Strategy was 
increased police presence and police involvement, yet there were no recommendations for harm 
reduction training for police. While the four guiding principles of the Toronto Drug Strategy are 
prevention, harm reduction, treatment and enforcement, to be applied in tandem, the continuance 
of prohibitionist type enforcement and policing challenges the ability of the document to address 
harm reduction and treatment, and a more general idea of “health”. What emerges here is the 
application of a “health” or “harm reduction” discourse that enables continued policing under the 
umbrella of the discourse.  
One of the biggest health concerns of a drug user is the quality or purity of the drug they 
are consuming. The Toronto Drug Strategy recognizes this concern under section 4.4, noting that 
users are at an increased risk of serious illness and overdose because they are unaware of the 
quality of drug they are using (City of Toronto, 2005, 30). However, the recommendation for this 
issue is to increase surveillance and police involvement to develop “a local drug and drug use 
surveillance system with protocols to issue broad-based alerts about potentially dangerous 
substances” (City of Toronto, 2005, 31). This proposal does nothing to address the associated 
health concerns. Increased police involvement is called for three more times in Chapter 5. 
Section 5.1 Support Neighbourhood Based Solutions, which calls for increased police presence 
in neighbourhoods.  Section 5.2 Address Drug-Related Crime in Rental Housing, advocates for 
“enforcement options such as blanket trespass orders that allow police to act on behalf of 
landlords, which should be considered to enable police to better assist landlords,” which would 
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effectively increase police presence in social and private rental housing and allow the police to 
enter private units, as if they were landlords (City of, Toronto, 2005, 44).  
Section 5.3, “Support Police Efforts to Enforce Drug Laws,” calls for the continued 
enforcement of prohibitionist drug laws (ibid).  This recommendation for increased police 
presence raises concerns for two reasons. The first is that there are no recommendations in the 
entire document about training police officers to properly approach drug users while they are 
consuming. While increased police involvement can succeed in reducing the visible aspects of 
street drug use, they are also associated with negative public health consequences, including 
reductions in needle exchange utilization, increases in syringe sharing, unsafe injecting and 
improper syringe disposal. The second issue that arises from increased police presence in a 
document that calls for harm reduction measures is a contradiction of costs. One of the economic 
appeals of harm reduction is that it is cheaper to prevent new infections than to pay for a lifetime 
of treatment. Insite, for instance, estimates that the long term cost of a new HIV infection is 
about $500,000 per infection (Insite Numbers, 2009). The Toronto Drug Strategy discusses the 
economic costs of drug use in section 4.9, stating that “the reality is that injuries and illness 
related to alcohol and other drug use have a serious financial impact on the primary health care 
system and therefore must be considered, especially within the context of preventing illness” 
(City of Toronto, 2005, 35). However, the single largest cost related to drug use is policing. The 
Toronto Drug Strategy, which denounces the cost of drug use to the health care system and 
advocates for harm reduction, is still prescribing an increase in police presence, which has been 
proven to be costly, ineffective in terms of stopping drug use, and potentially hazardous to the 
health of drug users. This example is indicative of how the rubric of health sometimes enables 
continued policing.  
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5. Supervised Injection Sites and the Toronto Print Media 
 
The Toronto print media, specifically newspapers, have been a major site of knowledge 
generation informing these discussions about the merits/demerits of a supervised injection site. 
More specifically, newspaper editorials and coverage have been the predominant source of 
information for the “general public” regarding a supervised injection site. These media sources 
draw heavily upon legal and scientific expertise.  
 This section offers a discourse analysis of editorials from three Toronto based 
newspapers, ranging in their social and political leanings – The Toronto Star, The Toronto Sun 
and the Globe and Mail. I chose articles from the late 1990s through to 2010 based on the key 
words “supervised injection sites”, “safe injection sites”, “drug use” and “Toronto.”  I read the 
articles with the following questions in mind. 1) How were drugs and drug users perceived?  2) 
Was drug use considered a criminal or a health problem?  3) How were SIS facilities perceived, 
as a solution or a problem? Based upon these questions, I read over 50 articles and formulated a 
thematic table that highlighted three key governmental sensibilities: 1) risk, which has become 
the new point of intervention for harm reduction under the umbrella of health; 2) the loss of the 
productive body, articulated as a social cost borne by the general public, and 3) the spatial and 
criminal implications of the addicted body, in which the physical presence of supervised 
injection sites and drug users in space has a perceived negative impact on the surrounding 
environment.  In this section, I examine each of these discourses in turn. 
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Thematic 1: Risk 
One of the main languages taken up in official attempts to rationalize and implement controls 
over substances is the language of risk.  Historically, risk was most often used to embed 
substances in the drug/crime nexus, justifying criminal justice responses to drug use. Risk is now 
being mobilized in the harm reduction movement, particularly around opiates (Moore, 2007, 62). 
Heroin specifically is the drug most often associated with injection drug use and supervised 
injection sites in media discourses. The harm reduction movement, which began in the 1980’s 
around the ‘discovery’ of the HIV/AIDS connection to injection drug use, lent to heroin the 
language of risk, in particular a risk to health (Moore, 2007, 83). Harm reduction as a technique 
emphasizes voluntary treatment rather than punishment of users and tries to minimize the stigma 
of the criminalization of drug users (O’Malley, 1999, 196). Thus, harm reduction has emerged as 
a movement that is in opposition to criminal justice and prohibitionist models of responses to 
drug use, emphasizing the mitigation of harms and the importance of “health.” However, harm 
reduction still seeks to govern drug users. Health and risks to health have become the new point 
of intervention for governmental stakeholders. Health risks are articulated as both a risk to an 
individual’s health and a risk to the greater public’s health, both physiological and economic. 
Instead of carceral responses, harm reduction recruits intravenous drug users in their own project 
of care, instilling regimes of self care and responsibilization. That is, the good drug user has the 
responsibility of practicing their use in a way that reduces the harms or risks to others.  
Risk is discussed in two ways in the editorials – risk to the drug users themselves, such as 
overdose and disease, and the risk of drug users to others, through exposure to live drug use, 
used paraphernalia left in public spaces, etc. However, notions of risk go beyond these 
discussions. An inherent component of discussions of risk is the possibility of prevention, and in 
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these editorials risk speaks to a larger project at hand, that is, instilling regimes of self-care. 
Many of the editorial discussions revolved around the risk associated with drug use and the 
ability of supervised injection sites to manage risk. Editorials adverse to Supervised Injection 
Sites objected to the ability of such facilities to manage risk and drug use on the idea that these 
sites actually perpetuate and encourage drug use.  
The intent is to reduce the risk to addicts, but to us it’s all part of enabling 
 them, instead of focusing on treatment and law enforcement (Toronto Sun, 
December 12, 2002). 
 
‘Harm reduction’ sites and services encourage illegal drug users and 
alcoholic street people to continue to ingest their poisons using clean 
equipment in a safe environment. The theory is that it will eventually lead to 
fewer overdoses and less open use of drugs on the street (Toronto Sun, 
October 18, 2005).  
 
Editorials that advocated for supervised injection sites did so on the basis that these sites reduce 
the risk (or harms) associated with drug use both to the drug user and to the population at large. 
By attempting to limit drug use to one geographic location in which it can be brought under 
surveillance, these editorials advocated physically concentrating the “locus of harm” because 
would be easier to limit the negative outcomes. The biggest emphasis on risk reduction focused 
on health related risks. Specifically, concerns with stopping the spread of diseases like AIDS, 
HIV and Hepatitis C among drug users, and stopping death from overdoses.  
... provides compelling evidence that initiatives targeting illicit drug users 
such as supervised injection sites have been effective in reducing overdose 
deaths, HIV and other infections; improving safety and order in the 
community; and saving costs for emergency services (Toronto Star, 
September 7, 2006).  
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 What is killing addicts? Some die of overdoses, because they are buying 
street drugs and using them in uncontrolled conditions. Others die of diseases 
linked to sharing of needles, such as AIDS of hepatitis C. (Globe & Mail, 
February 1, 2005).  
 
The second largest emphasis was on reducing the risk to the general public from drugs.  In 
particular the concern was with the open, visible and public nature of drug use. One of the 
intentions of supervised injection sites is to bring public drug use inside and under the 
supervision of medical professionals, which serves the dual function of bringing drug use under 
surveillance while also decreasing the visibility of drug use. The concern from the editorials was 
that the population at large should not be exposed to live drug use, nor should they be exposed to 
used paraphernalia left in public spaces, and by extension crime related to drug use.  
 
It is a logical progression from safe-injection sites: an attempt to bring hard-
core addicts under medical supervision, in the hope they will be less 
dangerous to society, and will live long enough to accept help (Globe & Mail, 
February 1, 2005).  
 
 Hey, we can see why they’d want to expand that great crack kit program [to 
include Supervised Injection Sites]. After all, its [sic] apparently so popular, 
the remains of the kits (complete with syringes) are turning up in places like a 
downtown park next to a school (Toronto Sun, October 19, 2005). 
 
The danger of public drug use, which in this context is more appropriately read as poor 
urban public drug use, is particularly prevalent throughout all of the editorials. Discourses of risk 
have become the predominant forum in which urban drug use is discussed. Part of framing drug 
use as an issue of risk is that it opens drug use up to calculated intervention. There has been a 
transfer in the language and in the way medical professions discuss drugs and drug use, from a 
discourse of dangerousness to a discourse of risk (Castel, 1991, 287). Drugs are dangerous, but 
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danger cannot be predicted, it is not quantifiable in a way that can be bench marked. Risk, 
however, can be determined, calculated and predicted. Risk is a way in which problems are 
constructed, viewed or imagined and dealt with. It is a probalistic technique where events are 
sorted into a distribution and the distribution is used as a means of making predictions to reduce 
harm (ibid). In the editorials, harm and risk can be read almost uniformly as interchangeable. 
Risk is a combination of abstract factors which render more or less probable the occurrence of 
undesirable modes of behaviour, in this case, spread of disease, death, and public drug use 
(Castel, 1991, 288). Harm reduction and supervised injection sites are in theory all about the 
reduction of risks. The emphasis surrounding supervised injection sites on reducing risk and 
reducing harm presents the possibility for a new mode of surveillance – systematic prevention 
(ibid). Supervised injection sites can be considered a form of surveillance in that the intended 
objective is to anticipate and prevent the emergence of undesirable events (illness, deviant 
behaviour, death) (ibid). Plainly put, they are intended to manage and prevent risk.  
Part of the normalization project of harm reduction, and supervised injection sites, is to 
transform drug users into appropriate consumers (that is, users who only consume inside SIS 
facilities). In the harm reduction movement “risk” implies that the locus of harm creation lies 
neither in the properties of drugs, nor in the characteristics of the user, but in the variable yet 
calculable relationship between them (O’Malley, 1999, 197-198). One of the core principles of 
harm reduction is that risk probabilities can be calculated and thus known and governed 
(O’Malley,1999, 198). Risks and harms are recognized as not being an inherent quality in the 
drug or the user, but rather in the situations in which they are brought together (O’Malley and 
Valverde, 2004, 36). Governing the physical space in which the action of drug use happens, the 
site of risk, has become the focus of harm reduction and has provided the rationale for the 
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implementation of supervised injection sites. In earlier discourses of drug use, the intravenous 
drug user was depicted as a ‘slave’ to addiction, incapable of rational decision making and as 
living only for the next injection. In more recent discourses, particularly harm reduction, the 
intravenous drug using subject is a health-conscious citizen capable of rational decision making 
and self-regulation in keeping with risk-avoidance regimes and techniques (Moore, 2004, 1549). 
The changing “drug user” as a disorder is both created and maintained through current modalities 
and discourses of treatment, a process that now currently requires the individual’s docile 
commitment to the treatment regime (Johncke, 2009, 16). In this, the drug user is charged with 
managing risks to the self.  
The larger project of supervised injection sites is to install risk management as an 
“everyday practice of the self”, backed by a moral responsibility or duty to the self “to be well”, 
and the belief that each individual can acquire a personal preventative capacity (O’Malley, 1996, 
200). Health becomes the responsibility of the private individual. In the last 100 years there has 
been a shift in emphasis from controlling the dangerous individual, through face to face 
interventions and confinement, to anticipating and preventing the emergence of undesirable 
events, such as illness, abnormality and deviant behaviour (Petersen, 1997, 192-193). Since the 
mid-1970’s there has been a clear ideological shift away from idea that the state should protect 
the health of individuals to the idea that individuals should take responsibility to protect 
themselves from risk (Petersen, 1997, 194). This ethos can be read as part of the larger co-
emergence of neoliberalism. The neo liberal rationality emphasizes the “entrepreneurial 
individual”, who has freedom and autonomy and the ability to properly care for themselves 
(ibid). What emerges is a duality that the individual must strive for that consists of the 
responsible (moral) and of the rational (calculating) individual. The rational individual strives to 
  
33
become responsible for the self, the most effective provision for security against risk. The 
responsible individual will take rational steps to avoid and to insure against risk, in order to be 
independent rather than a burden on others (O’Malley, 1996, 199-200). As Petersen puts it, “neo-
liberalism calls upon the individual to enter into the process of his or her own-self governance 
through processes of self-examination, self-care and self-improvement”, and the care of the self 
is inextricably bound with the project of moderating the burden of individuals on society (1997, 
194). If one is unable to regulate one’s own lifestyle and risky behaviour, it is a failure of the self 
to take care of one’s self.  
 
Thematic 2: Loss of the Productive Body (the Dying Body) 
With supervised injection sites, users are encouraged to appreciate the “realities of their health” 
and to take responsibility for the care of their bodies while at the same time limiting potential to 
harm themselves or others by undertaking preventative actions (Fischer et al., 2004, 361). With 
SIS facilities drug users have become increasingly normalized as a responsibilized agent whose 
prime responsibility and “right” is to manage risk to themselves and others associated with drug 
use (Fischer et al., 2004, 358). ‘Normalization’ in the lexicon of harm reduction takes on the 
meaning of rendering illicit drug taking subjects as normal subjects of government (O’Malley, 
1999, 196). The object of normalization is to make illicit drug use a self-governing activity that 
does not, for the most part, require expert intervention. The goal of normalization is undertaken 
in order to more effectively govern drug users, to align “the wills of subjects” with the project of 
harm reduction, and to arrange the distribution of risks and harms with the objectives of 
government programs (O’Malley, 1999, 196). It is the drug user who is responsible for accessing 
the SIS facilities and ensuring that they only conduct their drug use on premises. In this context, 
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the drug user is made up as a “citizen subject”, the product of a regime of discipline that secures 
normalization by embedding a pattern of norms “disseminated throughout daily life and secured 
through surveillance” (Fischer et al., 2004, 362). The primary goal is to manage risk/harm, which 
in part requires drug users to consume only within supervised injection sites. The extension of 
this goal of risk/harm management is a responsibility for health management, implicit in which is 
an economic imperative regarding a body’s productivity.  
While the actual goal and outcome of supervised injection sites can be understood as 
managing the spatial realm of drug use, the productivity, and the loss of productivity of the drug 
using body has increasingly become a focus. Loss of productivity is understood as a physical 
state due to decreased health functioning, but has also been extended to encompass a socio-
economic perspective, that is, decreased participation in the work force, and as a further 
extension, the “societal” economic and monetary costs of drug use. Loss of productivity ties into 
the larger economic and monetary costs of drug use. In the editorials, the loss of productivity and 
the productive body due to drug use was often discussed as a social cost. This “cost” was 
understood as one borne both by the individual drug user (loss of physical health, loss of the 
ability to participate and contribute in the workforce) as well as the population (healthcare costs, 
decrease in labour pool). In the editorials it was measured in both economic terms of money 
spent and money lost, as well as the loss of life and functioning and decreased health.  
 The social cost of substance abuse in Canada is $40 billion a year…This 
dollar amount represents a terrible toll of tens of thousands of deaths, 
hundreds of thousands of years of productive life lost, and millions of days 
spent in hospital... (Toronto Star, September 7, 2006).  
 
No single method of trying to reach heroin users will work. Treatment usually 
means methadone – a substitute high – which at up to $5000 a year is a cost-
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effective way of reaching addicts for whom the costs in health, policing and 
lost productivity have been estimated at $50,000 annually [per user] (Globe 
& Mail, September 19, 2003).  
  
Supervised injection sites and other harm reduction techniques resonate in the editorials 
on the level of cost-effectiveness. The loss of productivity is both physical and economic, and 
supervised injection sites are appealing in that they can potentially decrease the health care costs 
associated with drug use. Advocates in the editorials also cited supervised injection sites as 
desirable because they are seen as a technique that will help to restore and regain lost 
productivity, noting the decreased functioning capacity of drug users and the potential to 
increase health.   
 Further there are benefits arising from the inclusion of previously 
marginalized members of society into mainstream life. The improved health 
and functioning of individuals and the net impact on harm in the community 
are notable indicators of the success of harm reduction (Toronto Star, 
September 7, 2006). 
 
Harm reduction is rooted in a pragmatic approach that focuses on improving 
overall health and well-being of individuals. It’s meant to focus on a problem 
that is causing a harm (Toronto Star, August 19, 2008). 
 
The idea that supervised injection sites are a panacea for the social, economic and health issues 
associated with drug use is somewhat troubling. The expectation that SIS facilities will improve 
the functioning and health of addicts and that the goal of these sites is to include those previously 
considered marginalized into mainstream society, with the intention of transforming such 
marginalized and disenfranchised individuals into cured, choice-making, self-regulating subjects, 
is a misunderstanding of how SIS facilities function. When discussing notions of freedom under 
liberalism there is an obligation to maximize one’s life. This is an obligation that is borne solely 
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by the individual (Moore, 2007, 62). In this sense, supervised injection sites can be considered a 
technology that is both autonomizing and responsibilizing, in that the creation of a SIS facility 
responsibilizes the drug user for making sure they use the site, use clean instruments and exercise 
so called safe injection practices. However, unlike other governmental institutions, like the 
prison or the factory, supervised injection sites do not seek to rehabilitate bodies or to make them 
productive again (Philo, 2001, 482-483). The purpose of these sites is simply to mitigate harms 
associated with drug use. They do not maximize life and do not enable individuals to do so. That 
is not to say that it is impossible for a SIS client to successfully access rehabilitation services, in 
fact almost all SIS facilities have connections or access to such programs. However, it is up to 
the user to seek out and participate in such programs. The main function of Supervised Injection 
Sites is simply to provide a supervised space for consumption.   
 
Thematic 3: Criminal and spatial implications of the addicted body 
While governmental approaches are starting to transition away from explicitly using the criminal 
identity for governance, it continues to persist in the media and public opinion. This transition is 
coupled with the emergence of “new public health”, which has resulted in the broadening of the 
focus of health promotion to include the ‘environment’, which is conceived broadly as spanning 
the local through to the global and including social, psychological and physical elements, such as 
the regulation of urban space (Petersen, 1997, 195). This new understanding has multiplied the 
number of sites for preventative action and has given rise to numerous “at risk populations and 
risky situations” (ibid). Supervised injection sites have emerged in the context of the 
advancement of globalization, in which cities have surpassed nation states to compete directly 
  
37
for global capital, in which the physical spaces of cities have taken on a new importance. The 
dominant rationale for urban order is no longer linked to the demands of the industrial city but to 
the role of cities as competitive nodes within the global economy (Gandy, 2006, 508). 
Intravenous drug users in western industrialized nations have traditionally been a phenomenon 
located in urban environments (Fischer et al., 2004, 358). With the advent of “global cities”, 
urban agendas have increasingly focused on the facilitation of economic activity and 
emphasizing the city as a space of consumption (Fischer et al., 2004, 359). Within this context, 
supervised injection sites have become appealing as a measure against the “contamination” of 
urban space by drug users who would disturb “neo-urban functionality, safety and aesthetics” 
(Fischer et al., 2004, 361). The body of the drug user in public space represents a threat to urban 
economic order and aesthetics. While previous criminal justice approaches have failed to 
eliminate public drug use, supervised injection sites seek only to take the public nature out of 
drug use, bringing it into a regulated and enclosed space.  
Regulation of the modern subject is connected with the strategic needs of the nation state 
(Gandy, 2006, 499). Since cities are surpassing the nation-state in this reorganization of global 
capital, citizens-as-subjects are being regulated in accordance of the needs of the urban 
jurisdiction. Since the 18th century the human body has become progressively incorporated into a 
nexus of architectural and regulatory structures to produce a new spatial order in the modern city 
(Gandy, 2006, 503). The politics of public health have involved a shift from a preoccupation 
with death to a focus on life in which “the health and physical well being of the population in 
general emerges as one of the essential objectives in political power” (ibid). With this 
recognition that the health of the population at large was profitable, and necessary to invest in 
and protect, the need to invent new kinds of control for the “dangerous” classes emerged (ibid). 
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Intravenous drug users are seen as representing a threat not only to consumption practices and 
economic activities, but also to the health of the population at large. In this context the drug user 
becomes a “disabled body” in urban space. Within space “disabled” people are forced to account 
for their different bodily performances, often shunned or formally excluded, and constantly feel 
pressure to perform as “normally” as they possibly can (Hansen and Philo, 2007, 496). The “non-
disabled body” is established as the “natural” way of appearing, being and doing. Everyday 
spaces (streets, parks, offices, etc) are “naturalised” as ones to be inhabited and used by non-
disabled people. Many bodies, such as the drug user (the dying body), do not “belong” in these 
spaces and their presence is treated as a form of trespass (ibid).  The very presence of a drug user 
in space is regarded as creating a potential criminal element. There are two facets to this.  First, 
addiction has become conflated with crime in many editorials. Second, the “criminal” element 
has a spatial implication and dimension. Several of the editorials objected to supervised injection 
sites because they felt having a known space in the city dedicated to drug use would bring a 
concentration of drug users into a neighbourhood, and as a result of this would attract crime and 
drug dealers, compromising neighbourhood safety.  
One area resident told her drug dealers love to hang around the places where 
the city gives out the kits…instant customers! (Toronto Sun, October 19, 
2005). 
 
That strategy proposes, among many other things, providing more, safer 
crack-use kits to addicts to ingest their illegal poisons – but safely. It also 
suggests looking at safe sites where drug users can smoke or shoot up while 
the pushers wait at the door to sell them their substances (Toronto Sun, 
October 25, 2005).  
 
        Some editorials felt that the crime they associated with SIS facilities and drug users also 
presented as a threat to local businesses, creating a dichotomy between legitimate and 
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illegitimate economies. “Many area merchants fear the sites will attract more addicts to their area 
and intimidate their customers.” (Globe & Mail, November 15, 2002). The editorials presented 
discussions about both the criminalization of the drug use and the criminalizing effect on space 
that the presence of drug users causes.  
Gilroy added that safe crack kits and injection sites are the ‘most ridiculous 
idea’ she’s ever heard of. ‘It’s preposterous to think there wouldn’t be 
violence outside of an injection site when drug dealers know where they are 
(Toronto Sun, October 25, 2005).  
 
First, who in Toronto, Montreal or Vancouver would want to live near a 
‘safe’ injection site’ – an oxymoron if we’ve ever heard one – as proposed by 
a Liberal-dominated parliamentary committee? Such a site would by 
definition attract drug users and dealers and prevent the police from enforcing 
the law (Toronto Sun, December 12, 2002).  
 
  Drug users, and by extension Supervised Injection Sites, are depicted as presenting a 
threat to public space because there is no way of guaranteeing that drug use is conducted solely 
in the facility and no way of guaranteeing continued facility usage. Thus there is a perceived 
threat of drug use occurring in the neighbourhood around the supervised injection site.  For these 
editorials, supervised injection sites are simply enabling criminal actions. However, the sites 
were also advocated for in some editorials on the advantages on having such a concentration of 
drug users from a law enforcement perspective. “Campbell and others argue that harm reduction 
efforts help police...” (Toronto Sun, October 25, 2005). SIS facilities were advocated for on the 
basis that it would make it easier to police and manage drug users, while at the same time 
addressing the spatial element of drug use by taking it out of highly visible public spaces. 
Supervised injection sites as a technique for dealing with drug addiction presents a useful entry 
point for authorities to govern other issues (Moore, 2007, 49). As previously discussed, 
  
40
substance abuse is a “problem” that is very scientifically accessible and can be read as an 
exclusively individual behaviour (Moore, 2007, 50). The drug addict and addiction are not 
natural truths; they are modern discoveries and identities that were exposed in order to facilitate 
a practice of governing (Moore, 2007, 125). Drug users, once identified, could be subject to 
appropriate interventions, guided by socio-economic status, race, gender, etc. (Moore, 2007, 
126).  This identification and association has particular relevance for supervised injection sites. 
Appropriate interventions for upper class people have usually meant rehabilitation clinics (ibid). 
For “others” (poor people), it has meant criminalization, forcible confinement, incarceration and 
disenfranchisement (ibid). Supervised injection sites are a technology/tool that are aimed at a 
very particular kind of drug user.  In these editorials it is addiction, not social inequality, which 
is at the root of criminalization. Addiction and drug use are also presented as the product of 
individual choice, thus implying that there is no socio-economic or structural explanation or 
“cure” for crime, because crime is a product of individual choice rather than social ills (ibid). 
The “crack addicted stock broker” mentioned in one editorial encapsulates who the subjects of 
supervised injection sites are.  
While some of society’s ‘marginalized’ users could indeed be contacted, 
many crack users, perhaps a majority, would remain out of reach. A crack-
addicted stock-broker, for example, isn’t likely to seek out a city-supplied 
safe kit, much less go to a public inhalation room to get high (Toronto Star, 
October 24, 2005).  
 
Supervised injection sites are not intended to reach the crack addicted stock broker; these sites 
are aimed at poor urban drug users who are not considered “high functioning” and do not have a 
private space to do drugs in, and thus practice drug use in public spaces. Supervised injection 
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sites can essentially be considered a management tool for addressing the intersection of poverty 
and drug use in cities. 
 
Conclusion: Prolonging an inevitable death 
 
 Supervised injection sites emerged out of the harm reduction movement at a time when 
governments started to publicly acknowledge that prohibitionist techniques failed to address the 
“drug problem.” This acknowledgement precipitated a transition to “health” based harm 
reduction techniques. This shift from punitive schemes to the government of drug users as a form 
of regulated risk consumption and socio-spatial ordering articulated under the rubric of health 
has provided a new point of access for the governance of drug users. As a mode of bio-power, 
health has become the new truth discourse that justifies supervised injection sites as the 
appropriate strategy to address intravenous drug use. SIS facilities enable the promotion of forms 
of subjectivity that align with larger governmental goals through the assigning of the “good drug 
user” identity.  This subjectivity has coincided with and is closely linked to the increasing social 
and economic importance of urban space that positions supervised injections sites as a key 
governmental space. In the quest for order in the city, supervised injection sites are sites of bio-
political struggle for urban space. They are a measure against the contamination of increasingly 
valuable urban real estate. As demonstrated by The Toronto Drug Strategy and the discourse 
analysis, there is a spatial and economic imperative for the creation of supervised injection sites 
in Toronto. All of these debates hinge on a notion of health, but supervised injection sites are not 
about health care.  They are access points in which the drug using body can become accessible to 
governance. “Health” has become a way to assign responsibility for a personal preventative 
capacity, essentially allocating to the drug user responsibility to conduct drug use in a way that 
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protects larger societal social and economic imperatives. This is not strictly nor necessarily in the 
best interests of the personal health of the person using drugs. Serious consideration needs to be 
given to what it means when “health” and “health care” are used to describe and justify 
supervised injection sites, as these facilities do not maximize life and do not enable individuals to 
do so. That is not their purpose. Yet this “misunderstanding” continues to perpetuate, further 
facilitating the ability of supervised injection sites to govern drug users. For the majority of drug 
users, all that supervised injections sites will ever do is briefly prolong the inevitable: an early 
death. This is a profound declaration regarding what kind bodies are valued in the city and what 
kinds of lives are worth protecting (see also Murray 2011). Before any supervised injection sites 
are deployed in Toronto, consideration needs to be given to who and what interests these 
facilities actually serve, and what real health care would mean for drug users.  
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